Health Enhancement Products, Inc. Expands Intellectual Property Development Effort With Preeminent Research Scientist and Patent Counsel
Arizona-based algae producer Health Enhancement Products (OTCBB: HEPI) has engaged preeminent research scientist Dr. William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences at the Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography and the Skaggs School of Pharmacy and Pharmaceutical Sciences located in the La Jolla campus of the University of California at San Diego.
Dr. Gerwick’s current research focuses on the discovery of bioactive molecules with potential anticancer, antibacterial, neurotoxic, antiviral, or anti-inflammatory activity from marine organisms, such as algae. The pathways by which these complex molecules are assembled form the basis of Dr. Gerwick’s research, using stable isotope tracer methods and NMR analysis. Many marine algae produce prostaglandin and leukotriene analogs that are strikingly similar to substances produced in the human body, and that have therapeutic value as potential pharmacological agents.